Ab­b­Vie puts $161M in­to new R&D site in Ger­many, will add 300 jobs

Ab­b­Vie is in­vest­ing around €150 mil­lion ($161 mil­lion) in­to an R&D site at its Rhineland-Palati­nate lo­ca­tion in Ger­many which it ex­pects to com­plete in 2027, the com­pa­ny an­nounced this week.

At a site that em­ploys more than 2,000 al­ready, the new build­ing will house more than 300 em­ploy­ees in on­col­o­gy, neu­ro­science and im­munol­o­gy. It adds to the ap­prox­i­mate­ly €250 mil­lion ($269 mil­lion) Ab­b­Vie has in­vest­ed in­to Ger­many since 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER